Pediatrics international : official journal of the Japan Pediatric Society · 2012
Long survival of congenital alveolar capillary dysplasia patient with NO inhalation and epoprostenol: effect of sildenafil, beraprost and bosentan.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kodama Yoshihiko, Tao Katsuo, Ishida Fumihiko, Kawakami Tadashi, Tsuchiya Keiji, Ishida Kazuo, Takemura Tamiko, Nakazawa Atsuko, Matsuoka Kentaro, Yoda Hitoshi
Аннотация
The case is described herein of a patient with alveolar capillary dysplasia with double-outlet right ventricle and duodenal atresia who survived for a remarkably long time. The newborn girl was born at a gestational age of 36 weeks and weighed 1926 g. One min after delivery the Apgar score was 4. The patient had persistent pulmonary hypertension (PH) and needed nitric oxide inhalation and i.v. epoprostenol all through her life. Although other oral medications for PH were tried, they could not be used in practice because of gastrointestinal complications. The patient died on the 237 th day of life as a result of worsening PH associated with infection.
Предметные рубрики MeSH
Administration, InhalationBosentanBronchodilator AgentsDose-Response Relationship, DrugDrug Therapy, CombinationEpoprostenolFatal OutcomeFemaleFollow-Up StudiesHumansInfant, NewbornNitric OxidePersistent Fetal Circulation SyndromePiperazinesPlatelet Aggregation InhibitorsPulmonary AlveoliPurinesSildenafil CitrateSulfonamidesSulfonesTime FactorsVasodilator Agents